ADAC Laboratories has added CEO to Andrew Eckert's list of titles, which already includes president and COO. Giving up the CEO mantle is David Lowe, who will remain chairman of the Milpitas, CA, nuclear medicine vendor. ADAC said the transition was part
Information systems unit also reports difficultiesNuclear medicine vendor ADAC Laboratories last month reported strong growth in third-quarter revenues and operating income, but the positive numbers were overshadowed by a disturbing shortfall in
The nuclear medicine community is catching its breath after a one-week strike at a Canadian nuclear reactor caused a brief cutoff of the supply of molybdenum-99, the raw material for the commonly used radiotracer technetium-99m. While the strike was
The U.S. Department of Energy is moving forward with plans to use a nuclear reactor in Albuquerque to produce molybdenum-99, the raw material for several radioisotopes used in nuclear medicine. The agency's effort, however, has not moved as quickly as it
The development of new nuclear medicine and MRI contrast agents is the focus of an alliance signed last month between Epix Medical and Dyax. The two Cambridge, MA, companies have agreed to join forces to spur development of agents to diagnose pulmonary
The world's supply of technetium, the most commonly used radioisotope in nuclear medicine, was imperiled last week after a Canadian union went on strike at the nuclear reactor that supplies the world with 75% to 90% of molybdenum-99, the raw material
MCD/AC may support cardiology applicationsADAC Laboratories isn't slowing down its effort to enhance the clinical utility of its Molecular Coincidence Detection (MCD) technology, which enables nuclear medicine physicians to image PET radioisotopes
PET manufacturer Positron kept a low profile at this month's Society of Nuclear Medicine meeting, as it is working out cash-flow problems that have dogged it for the past several months. While Positron executives attended the meeting, the company decided
Company now must prove system’s clinical utilityIs nuclear medicine in store for a new era in digital gamma camera design? Industry observers will find out shortly, as gamma camera developer Digirad of San Diego has received 510(k) clearance
Company will also display E.Cam from SiemensAt its Society of Nuclear Medicine booth, Toshiba America Medical Systems, of Tustin, CA, plans to highlight the processing speed of the latest version of its nuclear medicine workstation. Toshiba's
Solid-state digital gamma camera developer Digirad next week will display a completed prototype of its Notebook Imager system for the first time at a Society of Nuclear Medicine meeting, according to Karen Klause, president and CEO of the San Diego
At its booth at the Society of Nuclear Medicine meeting, nuclear medicine vendor SMV will feature images from recent clinical studies under way to validate new technologies ranging from artifact correction to high-energy coincidence detection imaging.In
SNM introduction may spell trouble for dual-head marketNuclear medicine vendor Picker International hopes to revive the moribund market for triple-head gamma cameras with a radically redesigned triple-head system that may unlock the potential of
Technique may be able to locate occult lesionsA nuclear medicine physician who has spearheaded the use of gamma cameras for breast imaging plans to discuss his latest research in a presentation at next month's Society of Nuclear Medicine meeting.
New model cuts price of flagship systemThe nuclear medicine group of Siemens Medical Systems plans to unveil a new fixed-angle version of its premium E.Cam gamma camera at next week's Society of Nuclear Medicine meeting in San Antonio. Going with
New system targets mid-tier variable-angle nicheNuclear medicine vendor Elscint, of Haifa, Israel, will unveil a new work-in-progress gamma camera at next week's Society of Nuclear Medicine meeting that is designed to take on the mid-tier
Mallinckrodt has added another agent to its line of nuclear medicine imaging products. The vendor has signed a five-year agreement with Medi-Physics to distribute Myoview, a technetium-based cardiac imaging agent that provides physicians a view of
ADAC Laboratories this month signed an agreement with asset management firm Novare of Cincinnati whereby ADAC will service nuclear medicine equipment in Novare's customer network of hospitals and healthcare organizations. ADAC of Milpitas, CA, will
ADAC Laboratories continues to roll smoothly. The Milpitas, CA, nuclear medicine company last week released second-quarter financial results that showed revenues climbing 20% and net income increasing 44%.For the quarter (end-March), the company posted
Glenn Epstein has been named president and COO of Intermagnetics General of Latham, NY, with responsibility for day-to-day operations. He was previously president of Oxford Instrument's nuclear measurements group. He replaces Charles Dannemann, who
Nuclear Associates of Carle Place, NY, has introduced a phantom designed specifically for quality assurance tests of computed radiography equipment. The Boston CR Test Tool enables users to calibrate CR scanners or compare conventional film-screen
Nuclear medicine vendor SMV America has received 510(k) clearance from the Food and Drug Administration for its Volumetric Coincidence Reconstruction (VCR) technique for its Vision FX-80 gamma camera. SMV, of Twinsburg, OH, joins ADAC Laboratories and
GE Medical Systems of Milwaukee and Elscint of Haifa, Israel, took another step toward finalizing their agreement to form a joint-venture company to develop and manufacture nuclear medicine equipment (SCAN 2/19/97). The vendors announced last week that
The nuclear medicine division of Siemens Medical Systems in Hoffman Estates, IL, has received 510(k) clearance for its Profile attenuation correction device for the E.Cam variable-angle dual-head gamma camera. Profile uses a multiple-line array of
Nuclear medicine vendor Park Meditech announced that it will actively seek a strategic partner to assist the company in maximizing its technology within the nuclear medicine market.The announcement came with the release of financial results for the first
